Abstract: Escherichia coli succinate dehydrogenase (SdhCDAB) catalyzes the oxidation of succinate to fumarate in the Krebs cycle, and during turnover, it produces superoxide radicals. SdhCDAB is a good model system for the succinate dehydrogenase (Sdh) found in the mitochondrial respiratory chain (complex II), as the subunits are structural homologues. Although mutations in sdh genes are reportedly associated with a variety of mitochondria-related diseases, the molecular mechanism of these diseases is poorly understood. We have investigated the effects of site-directed mutations around the heme (SdhD-H71L and SdhC-H91L), and at the ubiquinone-binding site (Q site; SdhC-I28E), on enzyme activity and production of superoxide radicals. The mutations SdhD-H71L and SdhC-I28E, but not SdhC-H91L, significantly reduce the succinate-ubiquinone reductase activity of the enzyme. All 3 mutant enzymes produce more superoxide than the wild-type enzyme, indicating that disturbance of the heme or the Q site can enhance superoxide production. The presence of a Q-site inhibitor reduces superoxide production significantly. Furthermore, the yield of superoxide is substrate dependent and increases with succinate concentration from 0.1 to 10 mmol/L. Our results indicate that, in SdhCDAB, the Q site with bound ubiquinone is an important source of superoxide radicals.
2 hydrophilic subunits (SdhA, which contains a flavin adenine dinucleotide (FAD) cofactor, and SdhB, which has 3 iron-sulfur clusters), and 2 hydrophobic membrane-anchor subunits (SdhC and SdhD, which accommodate a heme and a ubiquinone-binding site (Q site)). Electrons delivered from the substrate (succinate) to the FAD cofactor are transferred through the iron-sulfur clusters to the ubiquinone bound at the Q site. The crystal structure of SdhCDAB has been recently determined, and it shows that all edge-to-edge distances between each redox center in the electron-transfer pathway from the substrate binding site to the ubiquinone site are less than 14 Å (1 Å = 0.1 nm) (Yankovskaya et al. 2003) , the upper-limit range for physiological electron transfer (Page et al. 1999) .
The midpoint potentials of the SdhCDAB redox centers are arranged in such a manner that electrons flow from centers of low potentials to those of higher potentials, i.e., the relay starts from -79 mV (FAD) (Ohnishi et al. 1981) , through +10 mV (2Fe-2S cluster), +65 mV (3Fe-4S cluster) (Condon et al. 1985) (the 4Fe-4S cluster has a negative potential), +35 mV (the heme) (Kita et al. 1989) , and finally reaches to approximately +90 mV at the Q site (UQ/UQH 2 ) (Depew and Wan 1988) ). Thus, electrons are drawn from the substrate (succinate) through the electron-transfer pathway to the ubiquinone bound at the Q site. Mutations associated with these redox centers may cause significant shifts in their midpoint potentials. For instance, it has been reported that a mutation in the membrane-anchor subunit SdhD-H71Q results in a decrease of the midpoint potential of the heme from +35 mV (Kita et al. 1989) to -97 mV (Maklashina et al. 2001) .
Mutations in sdh genes have been found to associate with a variety of mitochondria-related diseases. It has been reported that mutations in the human sdhA gene can cause Leigh syndrome, a progressive neurodegenerative disease (Bourgeron et al. 1995 , Parfait et al. 2000 , whereas mutations in the sdhB, sdhC, or sdhD gene can result in paraganglioma (PGL) or pheochromocytoma tumors (Baysal et al. 2000; Niemann and Muller 2000) . Interestingly, it has also been shown that a mutation in the mitochondrial complex II of Caenorhabditis elegans CeSdhC-G71E (the mev-1 mutation) leads to enhanced superoxide production, oxygen hypersensitivity, and premature aging (Ishii et al. 1998; Senoo-Matsuda et al. 2001) . A recent study using a transgenic mouse cell line (SDHC E69), which has the equivalent mutation in the SDHC gene as the mev-1 mutation in C. elegans, has shown that this mutation causes superoxide overproduction in vivo, although in vitro superoxide production from the mutant is only slightly higher then that of the wild type (Ishii et al. 2005) . The authors have also shown evidence that superoxide overproduction from mitochondria leads to apoptosis and tumorigenesis (Ishii et al. 2005) .
These mutations associated with pathological phenotypes have strong effects on the succinate-ubiquinone reductase activity of succinate dehydrogenase (Sdh) (the activity of transferring electrons from succinate through the FAD and the iron-sulfur clusters to the Q site) but much less effect on the succinate dehydrogenase activity (the activity of transferring electrons from succinate to FAD cofactor and the iron-sulfur clusters). In the findings obtained from the mev-1 mutant of C. elegans, the authors showed that the mev-1 mutation had no effect on the succinate dehydrogenase activity of the Sdh but significantly reduced the succinate-ubiquinone reductase activity of the enzyme compared with that of the wild type (Ishii et al. 1998) . It was also previously reported that the succinate-ubiquinone reductase activity of Sdh was very low in the tumor tissues from patients with PGL (Gimenez-Roqueplo et al. 2001) .
The molecular mechanism of PGL tumor formation is not well understood. It was initially proposed that PGL tumor formation might be associated with superoxide (one of the so-called reactive oxygen species (ROS)) overproduction by Sdh caused by the mutations (Astuti et al. 2001; . This hypothesis was supported by the findings that the mev-1 mutation in the mitochondrial complex II of C. elegans results in enhanced superoxide production and oxygen hypersensitivity (Ishii et al. 1998; Senoo-Matsuda et al. 2001) . It is also supported by a recent study, using a transgenic mouse cell line with the equivalent mutation in the SdhC gene as the mev-1 mutation in C. elegans, which shows that this mutation causes superoxide overproduction from mitochondria that leads to apoptosis and tumorigenesis (Ishii et al. 2005 (Ishii et al. , 2006 . Subsequent to the superoxide overproduction hypothesis, additional research led to a new hypothesis, i.e., the metabolic signaling mechanism that describes succinate-mediated inhibition of prolyl hydroxylase (PHD) and induction of hypoxiainducible factor (HIF). These studies indicate that succinate accumulation in the cells caused by the dysfunction of mutant Sdh can lead to induction of HIF, resulting in enhanced glycolysis and tumor formation (Dahia et al. 2005; Pollard et al. 2005; Selak et al. 2005; Vanharanta et al. 2006) . However, this hypothesis has been challenged by clinical observations and other studies (for reviews on this subject, see Briere et al. 2005 Briere et al. , 2006 . Interestingly, it has been reported that ROS can also inhibit PHD activity and trigger tumor formation (Gerald et al. 2004; Kinnula and Crapo 2004) . Furthermore, Sdh dysfunction and ATPase deficiency are commonly associated, and in the latter case, overproduction of superoxide is observed . Therefore, there could be a link between the ROS and metabolic signaling pathways. Although the superoxide overproduction mechanism in PGL formation is still under debate, it is important to investigate the effect of mutations in Sdh on ROS production.
Superoxide production has been observed from the Sdh of both E. coli (Messner and Imlay 2002b ) and the yeast Saccharomyces cerevisiae (Guo and Lemire 2003) . However, controversy surrounds the site of superoxide production. For E. coli Sdh, only the wild-type enzyme was examined for the production of superoxide radicals. Based on the observation that an excess amount of substrate (succinate) reduced superoxide radical production (presumably, the binding of succinate to the FAD cofactor blocked the access of molecular oxygen to the cofactor), it was proposed that FAD was the site of formation of superoxide radicals (Messner and Imlay 2002b) . The study of Sdh from yeast (using both the wild-type and mutant enzymes) indicated, however, that the Q site was the source of superoxide, because a high concentration of succinate did not inhibit production of superoxide radicals, and mutations around the Q site resulted in enhanced superoxide production (Guo and Lemire 2003) . A study of the effect of mutations in E. coli Sdh on superoxide production has not yet been made, although such a study would provide important information for understanding the pathology of PGL at the molecular level.
As a structural homologue, SdhCDAB is a good model system for complex II in the mitochondrial respiratory chain. We have selected 3 site-directed mutations in the membrane-anchor subunits SdhD-H71L, SdhC-H91L, and SdhC-I28E to study the effects on enzyme activity and the production of superoxide radicals. Mutation SdhD-H71L is equivalent to HuSdhD-H102L, a mutation in human mitochondrial complex II associated with PGL. The residue SdhD-H71 is a heme ligand (Vibat et al. 1998 ) and points to the plane of the heme, and SdhC-H91 is on the edge of the heme (Yankovskaya et al. 2003) . These 2 mutations are important for assessing the role of the heme in electron transfer and production of superoxide in Sdh. Mutation SdhC-I28E is designed to mimic the mev-1 mutation in the mitochondrial complex II of C. elegans, which causes enhanced superoxide production and premature ageing. It is located at the Q site of the enzyme and is useful for examining the role of the Q site in the enzyme function and superoxide production. Furthermore, we have also investigated the effects of succinate concentration and the Q-site inhibitor pentachlorophenol (PCP) on the production of superoxide radicals.
Materials and methods

Bacterial strains and plasmids
Escherichia coli strain DW35 (ÁfrdABCD, sdhC::kan) was used to express SdhCDAB (Westenberg et al. 1993) . Plasmid pFAS was used for the high-level expression of SdhCDAB in E. coli (Maklashina et al. 1998 ).
Growth of cells, preparation of membrane vesicles, and analysis of protein content
Cell cultures were grown overnight in Luria-Bertani medium with appropriate antibiotics (35 mg/mL ampicillin and 50 mg/mL kanamycin) and harvested at late exponential phase as described previously (Maklashina et al. 1998 ). Cells were collected by centrifugation and the membrane fractions enriched in SdhCDAB were isolated as described previously (Maklashina et al. 1998) . Membranes containing the wild-type enzyme or the mutant enzymes were resuspended in 50 mmol/L potassium phosphate buffer containing 0.2 mmol/L EDTA (pH 7.2) and stored at -70 8C. Protein content was determined by a modified Lowry assay in the presence of 1% SDS using a Bio-Rad serum albumin protein standard (Markwell et al. 1978) . The enzyme concentration was determined by quantifying the concentration of ironsulfur clusters of the enzyme using the electron paramagnetic resonance (EPR) method (Paulsen et al. 1993) .
Enzyme activity assays
Sdh as isolated is usually partially inhibited by oxaloacetate. The enzyme (0.5 mg/mL) was therefore activated by incubation in 0.6 mol/L phosphate buffer (pH 7) at 30 8C for 20 min (Ackrell et al. 1978) . Two assays were carried out to measure the succinate dehydrogenase and succinateubiquinone reductase activity of the enzyme. One was the phenazine methosulfate (PMS) mediated reduction of 2,6-dichlorophenolindophenol (DCIP), which measures the assembly of the 2 hydrophilic subunits SdhA and SdhB and the succinate dehydrogenase activity of the enzyme. In this assay, electron transfer was initiated by adding 10 mmol/L succinate (all concentrations quoted were final concentrations) to the mixture containing 1 mg/mL Sdh, 0.75 mmol/L PMS, and 30 mmol/L DCIP, and 1 mmol/L KCN in 0.1 mol/L phosphate buffer at pH 7.8 and 25 8C. The reduction of DCIP was monitored at 600 nm and calculated using the extinction coefficient 600nm = 21 mmol/L -1 Ácm -1 (Hatefi 1978) . The other assay was the succinate-ubiquinone oxidoreductase assay (modified from reference Esposti 2001), which measures the succinateubiquinone reductase activity of the enzyme. To express Sdh from the pFAS plasmid, E. coli was grown microaerobically (Rothery et al. 2005) . Under these conditions, menaquinone, rather than ubiquinone, was the predominant quinone species present in the membranes and the concentration of the ubiquinone was estimated to be less than a few micromoles per litre. As E. coli Sdh only uses ubiquinone and cannot use menaquinone during its turnover, the ubiquinone analog Q 1 was supplied to the enzyme for the assay. In this assay, the reduction of DCIP mediated by ubiquinone analog Q 1 was measured after adding 10 mmol/L succinate to 0.1 mol/L phosphate buffer (pH 7.8) containing 1 mg/mL Sdh, 100 mmol/L Q 1 , 30 mmol/L DCIP, and 1 mmol/L KCN at 25 8C.
Superoxide assay
In this assay, the ubiquinone analog Q 1 was supplied to the enzyme for the same reason as that described for the succinate-ubiquinone reductase assay. To avoid interactions of cytochrome c with ubiquinol and other background enzymes associated with the membranes, acetylated cytochrome c (Sigma-Aldrich), was chosen for the superoxide assay (Lenaz et al. 2004) . KCN was added to the assay system to eliminate the effect of any cytochrome oxidase present in the membranes (Imlay and Fridovich 1991) . Because KCN can react with copper or zinc containing SOD (superoxide dismutase), manganese-containing SOD from E. coli (Sigma-Aldrich, St. Louis, Missouri) was used in all superoxide assays (Lenaz et al. 2004) .
The production of superoxide radicals was assayed using the SOD-dependent cytochrome c reduction method (Azzi et al. 1975; Imlay and Fridovich 1991; McCord and Fridovich 1969; Messner and Imlay 2002a) . The assay was performed at 25 8C by adding 0.1-10 mmol/L succinate to airsaturated 0.1 mol/L phosphate buffer (pH 7.8) containing 1 mg/mL Sdh, 20 mmol/L of acetylated cytochrome c, 50 mmol/L Q 1 , and 1 mmol/L KCN in the absence or presence of 30 units/mL SOD. The reduction of cytochrome c was measured at 550 nm for 5 min and calculated using the difference of the extinction coefficients of ferrocytochrome c and ferricytochrome c, (Fe 2+ cyt) 550nm -(Fe 3+ cyt) 550nm = 21 mmol/L -1 Ácm -1 (Imlay and Fridovich 1991) . Only the linear range of the data was analyzed to obtain the rate of superoxide production, and it usually lasted for 3-5 min; during this time period, the enzymes kept turning over. SOD-dependent cytochrome c reduction was induced by superoxide radicals and was calculated by subtracting the amount of cytochrome c reduced in the presence of SOD from that in the absence of SOD. Superoxide production per nmole of enzyme was calculated using the enzyme concentration determined by the EPR method (Paulsen et al. 1993) . The contribution of Q 1 itself to the superoxide production was negligible, because when the enzyme was absent in the reaction system, the amount of superoxide produced was less than 1% of the amount produced when the enzyme was present (data not shown). Furthermore, when the concentration of Q 1 was increased from 50 to 100 mmol/L, there was no increase in superoxide production, indicating that 50 mmol/L of Q 1 saturated all ubiquinone binding sites in the enzyme. The effect of PCP on superoxide production was investigated by pre-incubating 0.4 mmol/L PCP with the enzyme for 2 min before assays.
Spectrophotometry
Enzyme activity and superoxide assays were carried out at 25 8C using a Hewlett-Packard 8453 diode array spectrophotometer (Hewlett-Packard, Palo Alto, California).
Results
Mutations of SdhD-H71L, SdhC-H91L, and SdhC-I28E do not affect succinate dehydrogenase activity
We examined the effects of 3 site-directed mutations, SdhD-H71L, SdhC-H91L, and SdhC-I28E, on succinate dehydrogenase activity (the activity of transferring electrons from succinate to FAD cofactor and the iron-sulfur clusters) by the PMS-mediated reduction of DCIP (PMS-DCIP assay) (Hatefi 1978) . None of the mutations SdhD-H71L, SdhC-H91L, or SdhC-I28E caused a drastic change of the succinate dehydrogenase activity compared with the wild type, as determined by this assay (Table 1 ). This is understandable, since these mutations are all located in the membraneanchor subunits, which do not participate in the PMS-DCIP assay. Nevertheless, the result indicated that the subunits SdhA and SdhB in the mutant enzymes were properly assembled on the membrane, since these mutations did not cause a loss of the enzyme activity.
Mutations SdhD-H71L and SdhC-I28E reduce succinateubiquinone reductase activity of the enzyme
The second assay we adopted was the succinate-ubiquinone oxidoreductase assay modified from that of Esposti (2001) . This assay assesses the succinate-ubiquinone reductase activity of the enzyme, the activity of transferring electrons from succinate through the FAD and the iron-sulfur clusters to the Q site. In contrast to the PMS-DCIP assay, this assay showed clear effects of mutations SdhD-H71L and SdhC-I28E on succinate-ubiquinone reductase activity (Table 1) . The succinate-ubiquinone reductase activities of SdhCD H71L AB and SdhC I28E DAB were reduced by 23% and 33%, respectively, compared with that of the wild-type enzyme. This result indicated that these mutations altered the physiological function of the enzyme, as the assay requires the biological electron transfer from the FAD cofactor to the Q site located in the membrane-anchor subunit.
SdhD-H71 is a ligand of the heme, and it is likely that mutation SdhD-H71L causes a strong perturbation to the heme, resulting in a decrease in the succinate-ubiquinone reductase activity of the enzyme (Table 1) . SdhC-H91, on the other hand, is on the edge of the heme and its mutation may not cause significant disturbance to the heme. Therefore, mutation SdhD-H71L is expected to have a greater effect on succinate-ubiquinone reductase activity than SdhC-H91L (Table 1) . SdhC-I28 is located at the Q site (Yankovskaya et al. 2003) ; thus, mutations of SdhC-I28E may disturb the structure of the site, causing reduced enzyme activity (Table 1 ). These results indicate that both the Q site and the heme are involved in the electron transfer processes during enzyme turnover. In other words, they both could be the structural components of the electron-transfer pathway in E. coli Sdh, although the crystal structure shows that the electron-transfer pathway is branched from the 3Fe-4S cluster to the Q site and to the heme (Yankovskaya et al. 2003) . A recent study has supported this conclusion that electrons must go through the Q site to get to the heme (Tran et al. 2006) . Table 1 shows a comparison of enzyme activities determined by the PMS-DCIP and succinate-ubiquinone oxidoreductase assays.
Presence of PCP at the ubiquinone-binding site reduces the succinate-ubiquinone reductase activity of the enzyme Pentachlorophenol (PCP) is a ubiquinone analog and it can bind to the Q site in Sdh. PCP is a competitive inhibitor of the enzyme and it cannot replace the role of ubiquinone to accept electrons and mediate electron transfer. Table 2 shows the changes of the succinate dehydrogenase and succinateubiquinone reductase activities of the wild-type and mutant enzyme in the presence of PCP compared with that in the absence of PCP. In the presence of 0.4 mmol/L PCP, the succinate-ubiquinone reductase activities of the wild-type and mutant enzymes were reduced by at least 50%. However, PCP had less effect on succinate dehydrogenase activity (Table 2) , since the succinate dehydrogenase activity assay does not measure the electron flow to the Q site.
Mutations of SdhD-H71L, SdhC-H91L, and SdhC-I28E increase superoxide production from the enzyme Table 3 shows the increase in superoxide production from Succinate dehydrogenase activity was determined by the reduction of DCIP mediated by PMS, as described in the text.
c Succinate-ubiquinone reductase activity was determined by the reduction of DCIP mediated by Q 1 , as described in the text.
the mutant enzymes compared with that of the wild type at different succinate concentrations. At a given concentration of succinate, all 3 mutant enzymes SdhCD H71L AB, SdhC H91L DAB, and SdhC I28E DAB produced more superoxide radicals than the wild-type enzyme. The enhancement of superoxide production by mutant enzymes SdhCD H71L AB and SdhC H91L DAB was calculated to be from 80% to over 100%, and SdhC I28E DAB also produced 60% more superoxide radicals than the wild-type enzyme. In the absence of succinate or Sdh, the amount of superoxide radicals produced was less than 1% of the amount produced in the presence of succinate or the enzyme (data not shown), indicating that superoxide radicals were produced by Sdh rather than via other enzymes in the membranes. It also indicates that the contribution of Q 1 itself to the superoxide production was negligible.
To investigate the effect of succinate concentration on superoxide production, 0.1, 1.0, and 10 mmol/L succinate was used in the assay. It was found that the production of superoxide radicals was dependent on the concentration of the substrate, succinate, and that the higher the succinate concentration, the greater the yield of superoxide radicals from the enzyme ( Fig. 1 and Table 3 ). This result agrees with that observed for the yeast Sdh (Guo and Lemire 2003) , but is contradictory to that previously obtained from the E. coli Sdh (Messner and Imlay 2002b ). In the latter study, an optimal succinate concentration for superoxide production was observed at about 0.1 mmol/L and at the higher concentration, the yield of superoxide decreased (Messner and Imlay 2002b) . It should be pointed out, however, that the E. coli enzyme used in that study was expressed from a mutated ubiquinone-deficient E. coli strain. This could result in a limitation of the yield of superoxide by the availability of ubiquinone in the membrane. Interestingly, when we used an enzyme fraction with limited ubiquinone in the membrane (due to the microaerobic expression) and without exogenous ubiquinone, we observed a succinate-concentration dependent profile of superoxide production that was very similar to that reported (Messner and Imlay 2002b) , with an optimal succinate concentration for superoxide production at about 0.1 mmol/L and a decrease of superoxide yield at higher succinate concentrations (data not shown).
Mutations SdhD-H71L and SdhC-H91L are located around the heme, and they both enhanced superoxide production. Thus, this result suggests that the heme has an influence on the production of superoxide radical by the enzyme. SdhC-I28 is located at the Q site, and mutation of this residue results in a disturbance to the Q site, as shown by a 33% decrease in succinate-ubiquinone reductase activity (Table 1) . It is clear that disturbance of the Q site can lead to increased superoxide production (Table 3) . Furthermore, it implies that the Q site could be a source of superoxide.
Presence of PCP at the ubiquinone-binding site reduces superoxide production
To examine the role of the Q site, the SOD-dependent cytochrome c reduction assay was carried out in the presence or absence of PCP. Table 4 summarizes the effects of PCP on superoxide production from the wild-type and the mutant enzymes. As shown in Table 4 , in the presence of 0.4 mmol/L PCP, the production of superoxide was reduced by 46%, 49%, 67%, and 41% from SdhCDAB, SdhCD H71L AB, SdhC H91L DAB, and SdhC I28E DAB, respectively, compared with that in the absence of PCP. This result indicated that binding PCP at the Q site resulted in a reduced production of superoxide radicals from the enzyme.
Although PCP is a ubiquinone analog, it cannot act as a ubiquinone to accept electrons and mediate electron transfer in Sdh. Thus, in the presence of PCP, the succinateubiquinone reductase activity of the enzyme was reduced by at least 50% (Table 2) . One may think that the decrease in superoxide yield in the presence of PCP might be due to the inhibition caused by PCP to the enzyme. However, this may not be necessarily true. For instance, mutations SdhD-H71L and SdhC-I28E reduce the succinate-ubiquinone re- Succinate-ubiquinone reductase activity was determined by the succinate-ubiquinone oxidoreductase assay, as described in the text.
c Changes in the enzyme activity observed in the presence of PCP are relative to that in the absence of PCP. Fig. 1 . Succinate-concentration dependent profile of superoxide production. The production of superoxide radicals from the wildtype (diamonds), as well as mutant E. coli Sdh enzymes SdhCD H71L AB (squares), SdhC H91L DAB (triangles), and SdhC I28E-DAB (circles) were investigated using 0.1, 1.0, and 10 mmol/L succinate (for other conditions, see the text).
ductase activity of the enzyme significantly (Table 1 ), but they enhance superoxide production (Table 3) .
Discussion
Effects of the mutations on the enzyme activity
Our finding that the PGL-related mutation SdhD-H71L significantly reduces the succinate-ubiquinone reductase activity of E. coli Sdh qualitatively agrees with the reported clinical observation that Sdh activity was very low in tumor tissues from patients with PGL (Gimenez-Roqueplo et al. 2001) . Furthermore, the results of the mev-1 mutation equivalent SdhC-I28E (Table 1 ) also qualitatively agree with the published data obtained from the mev-1 mutant of C. elegans. In that study, the authors found that the mev-1 mutation did not alter the succinate dehydrogenase activity of the Sdh, but reduced the succinate-ubiquinone reductase activity of the enzyme (Ishii et al. 1998) . Since this mutation is located in the membrane-anchor subunit close to the Q site, it was expected that the mutation would only affect the succinate-ubiquinone reductase activity, presumably as a result of the disturbance in the environment of the Q site.
The effects of mutations SdhD-H71L and SdhC-I28E on succinate-ubiquinone reductase activity (although greater than 23% and 34%, respectively) were much smaller than those observed in tumor tissues, C. elegans, and yeast (Gimenez-Roqueplo et al. 2001; Guo and Lemire 2003; Ishii et al. 1998 ). This may imply that E. coli Sdh behaves differently from the mammalian or eukaryotic homologs. Furthermore, it is important to note that a patient has been identified with PGL carrying a mutation located in the highly conserved protein motif forming the quinone-binding site of E. coli Sdh (Selak et al. 2005) , suggesting that the study of E. coli Sdh can still provide us with important information for better understanding the mammalian or eukaryotic enzymes, as they are homologs.
Heme may play a role of suppressing superoxide production
Here we showed that the site-directed mutations SdhD-H71L and SdhC-H91L around the heme result in enhanced superoxide production (Table 3) , leading us to propose that the heme may play a role in superoxide suppression by the enzyme. E. coli fumarate reductase (FrdABCD), which has a very similar structure to SdhCDAB. It consists of a catalytic subunit with an FAD cofactor, an electron-transfer subunit having iron-sulfur clusters, and 2 membrane-anchor subunits with menaquinone binding sites (Iverson et al. 1999 ). However, unlike SdhCDAB, FrdABCD does not have a heme in the membrane-anchor subunits. Under aerobic respiration conditions, FrdABCD produces 20-fold more superoxide radicals than SdhCDAB (Messner and Imlay 2002b) . Theoretical calculations have shown that FAD in FrdABCD has 50 times greater electron density than FAD in E. coli Sdh. More interestingly, it has been suggested that if heme is absent in E. coli Sdh, the electron density on FAD in the enzyme would increase 9-fold in a heme-free variant of the enzyme (Yankovskaya et al. 2003) . These calculations suggest that heme in E. coli Sdh functions as an electron sink, drawing electrons away from the FAD, resulting in much less superoxide production than that of FrdABCD. On the other hand, using superoxide assays, whe have shown experimentally that in E. coli Sdh, a disturbance to the heme caused by site-directed mutations SdhD-H71L and SdhC-H91L leads to enhanced superoxide production. Therefore, we propose that the heme in E. coli Sdh may play a role in suppressing superoxide production. More studies are needed to prove or disprove this hypothesis.
Q site with bound ubiquinone is an important source of superoxide formation
It was reported previously that an excess amount of succinate can block the autoxidation of FAD, presumably by occupying the flavin catalytic site and thus reducing superoxide production (Messner and Imlay 2002b) . Therefore, FAD was proposed to be the site of superoxide produc- a Superoxide production was assayed using the SOD-dependent cytochrome c reduction method, as described in the text. Superoxide production was assayed using the SOD-dependent cytochrome c reduction method, as described in the text. The decrease in superoxide production in the presence of PCP is relative to that in the absence of PCP.
tion in E. coli Sdh (Messner and Imlay 2002b ). However, as described in the Results section, the enzyme used in that study was expressed from a ubiquinone-deficient E. coli strain in which the availability of ubiquinone in the membrane is very limited. Moreover, when we used an enzyme fraction with limited ubiquinone in the membrane (a result of microaerobic expression) and without exogenous ubiquinone, we observed a succinate-concentration dependent profile of superoxide production (data not shown) that was very similar to that reported previously (Messner and Imlay 2002b) . On the other hand, when a sufficient amount of membrane-bound ubiquinone is available, the production of superoxide radicals increases with the increase in succinate concentration (Table 3) . We conclude that, under conditions of limited membrane-bound ubiquinone, the succinate-concentration dependence of superoxide production was caused by the limited availability of membrane-bound ubiquinone. Therefore, the observation of decreased superoxide yield at higher succinate concentrations may not support the conclusion that FAD is the site of superoxide production in E. coli Sdh.
Our results show that superoxide production is proportional to the concentration of succinate (Fig. 1) , further indicating that superoxide radicals are produced from Sdh that is not from another enzyme present in the system. At 10 mmol/L succinate, all flavin catalytic sites should be occupied by succinate, and flavin auto-oxidation should be prevented (Messner and Imlay 2002b) . However, the yield of superoxide increases further instead of decreasing, in agreement with the yeast data (Guo and Lemire 2003) . This leads us to propose that the Q site, rather than the FAD site, is the source of superoxide production in E. coli Sdh.
The displacement of membrane-bound ubiquinone by the Q-site inhibitor PCP significantly reduces the superoxide yield (Table 4) . PCP can compete with ubiquinone for the Q site. Binding PCP at the Q site can lead to reduced electron flow to this site because less membrane-bound ubiquinone is available to mediate electron transfer. Thus, the decrease in superoxide yield observed in the presence of PCP further suggests that the Q site with bound ubiquinone is an important source of superoxide formation in E. coli Sdh.
It has been reported that the semiquinone radical is not stabilized in the wild-type FrdABCD but it is clearly observed after mutating the residue associated with the Q site in the enzyme (FrdC-E29L) (Hagerhall et al. 1999) . However, it has been proposed that a semiquinone radical is stabilized in mammalian Sdh (Ruzicka et al. 1975) . A semiquinone radical has been observed in the Sdh from Paracoccus denitrificans (Waldeck et al. 1997 ). More recently, in E. coli Sdh, a stable semiquinone radical has also been observed in the wild-type enzyme (Tran et al. 2006) . These findings suggest that destabilized semiquinone radicals at the Q site could be the source of superoxide formation, since we know that, when reduced by succinate under aerobic conditions, FrdABCD produces much more superoxide than SdhCDAB. Residue SdhC-I28 is conserved in human, mouse, and E. coli Sdh and is located at the Q site of the enzyme. Mutation of this residue leads to an alteration of the site, as shown by a 33% drop in succinate-ubiquinone reductase activity of the enzyme (Table 1) . When Sdh is reduced by succinate, electrons are transferred from FAD through the iron-sulfur clusters to the Q site and semiquinone radicals are formed by one-electron reduction of ubiquinones bound at the site. The alteration of the architecture of the Q site could destabilize the semiquinone radicals by enhancing either the decay of the radicals (by losing an electron) or the release of them from the site. In both cases, the rate or the probability of the one-electron reduction of molecular oxygen by semiquinone radical would be increased, resulting in enhanced superoxide production. Therefore, disturbance of the Q site leads to an increased superoxide production (Table 3 ), demonstrating that a functional Q site plays a role of regulating superoxide production.
However, we cannot rule out that FAD, and possibly the iron-sulfur clusters, may also be a source of superoxide formation under some circumstances. It has been proposed that in mitochondrial complex I, an iron-sulfur cluster is the main source of superoxide (Genova et al. 2001 . However, superoxide production from the FAD site in E. coli Sdh may only become predominant when the electron flow to the iron-sulfur clusters is blocked.
Deleterious effects of mutations and tumor formation
Our findings demonstrate that the 3 site-directed mutations SdhD-H71L, SdhC-H91L, and SdhC-I28E lead to an increase in superoxide production compared that of the wild-type enzyme. Mutation SdhD-H71L, equivalent to HuSdhD-H102L (a mutation in human mitochondrial complex II associated with PGL), enhances superoxide production by more than 80%. Mutation SdhC-I28E (equivalent to the mev-1 mutation in the mitochondrial complex II of C. elegans) increased superoxide production by more than 60% (Fig. 1) . One may wonder whether the 60% increase in superoxide production would be sufficient to have a pathological impact to the tissue. It should be emphasized that the tissue damage could be induced by the accumulation of this low-level increase in ROS production over a long period of time. A recent in vivo study using a transgenic mouse cell line (SDHC E69) with the mutation in the SDHC gene equivalent to the mev-1 mutation in C. elegans has shown that superoxide overproduction and DNA damage caused by this mutation increase with time (during the 1-3 months during which the study was carried out) (Ishii et al. 2005) . It was also demonstrated that superoxide overproduction from mitochondria eventually results in apoptosis and tumorigenesis (Ishii et al. 2005) .
As mentioned earlier, metabolic imbalance and dysfunction of the tricarboxylic acid cycle can also trigger tumor formation (Briere et al. , 2006 Dahia et al. 2005; Pollard et al. 2005; Selak et al. 2005; Vanharanta et al. 2006) . Mutations SdhD-H71L and SdhC-I28E cause a significant decrease in the succinate-ubiquinone reductase activity of the enzyme (Table 1 ) and this can lead to decreased ATP synthesis and reduced capability of keeping the ubiquinone pool in the mitochondrial respiratory chain in a reduced status. This could in turn affect the functions of other enzymes associated with Sdh in the mitochondrial respiratory chain (mitochondrial complexes I, III, and IV). Deficiencies in the enzymes in the respiratory chain could lead to loss of the antioxidant ability of the respiratory chain, and dysfunction of Sdh could result in the accumulation of succinate, both of which factors can trigger tumor formation.
